Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average) (2016 - 2026)

Collegium Pharmaceutical has reported Shares Outstanding (Weighted Average) over the past 11 years, most recently at $31.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 1.76% year-over-year to $31.7 million; the TTM value through Dec 2025 reached $31.7 million, down 1.76%, while the annual FY2025 figure was $31.7 million, 1.76% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $31.7 million at Collegium Pharmaceutical, roughly flat from $31.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $35.4 million in Q3 2021 and troughed at $31.6 million in Q3 2025.
  • A 5-year average of $33.4 million and a median of $33.7 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 2.64% in 2021 and later dropped 6.32% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $34.9 million in 2021, then decreased by 3.17% to $33.8 million in 2022, then decreased by 0.26% to $33.7 million in 2023, then dropped by 4.35% to $32.3 million in 2024, then dropped by 1.76% to $31.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for COLL at $31.7 million in Q4 2025, $31.6 million in Q3 2025, and $31.8 million in Q2 2025.